After much advocacy, the Centers for Medicare & Medicaid Services (CMS) has initiated a National Coverage Determination process for adding Hepatitis B screening of high risk individuals as a covered Medicare preventive service.
The public can provide comments to CMS in support of this policy change. (deadline Feb 20, 2016)
To comment, click here
For more information about the policy, click here
Last Updated on January 25, 2020 by HepFree NYC
To determine the impact of the NYS Hepatitis C Testing Law, the NYSDOH drew from multiple data sources that assessed testing levels in New York before and after the law went into effect.
The NYS attorney general has asked 16 health insurance companies for information on their coverage of Hepatitis C treatments, amid concerns that some companies are restricting coverage of the medications.
NYS Medicaid Removes Hep C Experienced Provider Requirement from Prior Authorization Criteria
The Centers for Medicare and Medicaid Services (CMS) made the final decision to cover screening for hepatitis B infection at no cost to individuals entitled to benefits under Medicare Part A or enrolled in Medicare Part B.
The letter urges support for increased funding for viral hepatitis in the FY2018 appropriations bills.
Sign the letter urging Secretary Sebelius to ensure that Medicare incorporates hepatitis C screening into the Welcome to Medicare exam and the Medicare annual wellness visit.
Please help us protect Medicaid consumers and their healthcare providers, by asking Governor Cuomo to please sign bill A.10248B/S7384A, requiring the Health department to create a standardized form that all Medicaid Managed Care plans would have to use for the pharmacy benefit.
Coalition against Hepatitis in People of African Origin (CHIPO) NYC Chapter – Quarterly Meeting Highlights - January 19, 2022
){kind=link}